Multi Omics analysis and interpretation for diagnostics
Susan Mockus
Researcher at JAXI think multi-omics is just on the cusp of being integrated and used commercially by healthcare organizations for diagnostics. There are two factors driving this: 1. immuno-oncology and 2. resistance to targeted therapies. There are a number of commercial companies now offering multi-omic assays. The lag in adoption is typical, esp. given the complex nature of the data interpretation.
1 upvotes
Reply
Posted: 6 months ago
Vishu Mehta
Researcher at Bletchley LabHello @Susan.Mockus.57:u, thank you so much for the reply. It's really helpful, I really appreciate it.
0 upvotes
Reply
Posted: 5 months ago
Vishu Mehta
Researcher at Bletchley LabMulti Omics analysis and interpretation for diagnostics
Hey @smock2020:u. Greetings...... Roy Granit referred your name for this particular query. Surely you will be able to help me with it. I was wondering, if multi - omics analysis approach is being used commercially by healthcare organizations for diagnostics. How viable this approach is or will be in near future? I thank you in advance for your guidance.